Faculty profile
Franz Zemp
Back to facultyResearch
Read how they describe their research on their University of Calgary profile.
Latest papers
Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.
Genome biology · 2024
The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
PloS one · 2021
Rhabdoviruses as vaccine platforms for infectious disease and cancer.
Biotechnology & genetic engineering reviews · 2018 · first author
Latest funding
- $1,181,926
Conditioning the Tumor and Empowering the Cell: A New Paradigm for CAR T Therapy in Soft Tissue Sarcomas
CIHR · 2026 · Co-investigator
- $2,796,075
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
CIHR · 2023 · Co-investigator
4 publications.
Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.
Manoharan VT, Abdelkareem A, Gill G, Brown S, Gillmor A, Hall C, Seo H, Narta K, Grewal S, Dang NH, Ahn BY, Osz K, Lun X, Mah L, Zemp F, Mahoney D, Senger DL, Chan JA, Morrissy AS
The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Hildebrand KM, Singla AK, McNeil R, Marritt KL, Hildebrand KN, Zemp F, Rajwani J, Itani D, Bose P, Mahoney DJ, Jirik FR, Monument MJ
Rhabdoviruses as vaccine platforms for infectious disease and cancer.
Zemp F, Rajwani J, Mahoney DJ
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
Pisklakova A, McKenzie B, Zemp F, Lun X, Kenchappa RS, Etame AB, Rahman MM, Reilly K, Pilon-Thomas S, McFadden G, Kurz E, Forsyth PA
Conditioning the Tumor and Empowering the Cell: A New Paradigm for CAR T Therapy in Soft Tissue Sarcomas
Principal investigators: Monument, Michael J
Keywords: Car T Immunotherapy; Mouse Models; Sarcoma; Single Cell Rna Sequencing; Sting Immunotherapy; Tumor Radiation
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
Principal investigators: Shafey, Mona; Abdul Razak, Albiruni R; Hay, Kevin A; Henning, Jan-Willem; Kekre, Natasha; Mahoney, Douglas J; Morrissy, Sorana A; Noujaim, Jonathan; Simmons, Christine E
Keywords: Alveolar Soft Part Sarcoma; Car T; Immunotherapy; Renal Cell Carcinoma; Sarcoma; Triple-Negative Breast Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Douglas Mahoney and Franz Zemp: 1 shared paper
- Franz Zemp and Ebba Kurz: 1 shared paper
- Department of Biochemistry and Molecular Biology
- Department of Microbiology, Immunology and Infectious Diseases
- Physiology & Pharmacology
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 27, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.